The Tim Ferriss Show Transcripts: Dr. Dominic D’Agostino — All Things Ketones, How to Protect the Brain and Boost Cognition, Sardine Fasting, Diet Rules, Revisiting Metformin and Melatonin, and More (#825)
Please enjoy this transcript of my interview with Dr. Dominic D’Agostino (@DominicDAgosti2), a tenured associate professor in the Department of Molecular Pharmacology and Physiology at the University of South Florida Morsani College of Medicine and a Visiting Senior Research Scientist at the Institute for Human and Machine Cognition. He teaches medical neuroscience, physiology, nutrition, and […]
WHO adds GLP-1 drugs for diabetes, others to essential medicines list
The Vishwa Swasthya Sangathan has included GLP-1 drugs for diabetes in its essential medicines list. This move aims to enhance global access to these costly treatments. The list also features drugs for cystic fibrosis and cancer. The inclusion is expected to facilitate access in poorer countries. The organization also added rapid-acting insulin analogues.
FDA Tightens Control Over Obesity Drug Ingredient Imports Amid Safety Concerns
The U.S. Food and Drug Administration is tightening oversight of imports of GLP-1 drug ingredients, used for weight loss and diabetes, amid concerns that many of the items may be adulterated and pose a safety risk. The move comes as the FDA cracks down on unapproved compounded drugs, which had filled the gap during shortages […]
WHO adds GLP-1 weight loss drugs to list of the world’s essential medicines for the first time
The Inclusion of the weight loss medicine to the list should boost access to the drugs in poorer countries
Ozempic ingredient added to WHO’s essential medicines list
The World Health Organization has added GLP-1 drugs to treat diabetes to its essential medicines list alongside treatments for cystic fibrosis and cancer, and said it hopes this will help improve global access to the costly drugs.
1 in 4 US Adults With Diabetes Used Injectable GLP-1 Drugs Last Year
Between 2016 and 2022, the rate of US adults with type 2 diabetes who used glucagon-like peptide-1 (GLP-1) receptor agonists rose from about 4% to nearly 20%, according to the Medical Expenditure Panel Survey Household Component. Now, new data from the Centers for Disease Control and Prevention reveal that almost 27% of adults diagnosed with […]
The Information Survey: More Than Half of Respondents Take a GLP-1
It’s not exactly news that Ozempic, Wegovy and other GLP-1 drugs are catching on, with some surveys showing nearly 12% of Americans have used the weight loss medications. The Information’s audience seems to be even more gung-ho about taking GLP-1s than the broader population. More than 50% of the respondents to our recent survey on […]
WHO adds weight-loss, diabetes drugs to essential medicines list
UN agency urges production of affordable generics for GLP-1 drugs to treat obesity and diabetes in developing countries.
WHO has added GLP-1 drugs to the essential medicines list. Here’s what that means
GLP-1 drugs were initially developed for diabetes, but have become wildly popular weight-loss drugs too
US FDA Sends Import Alert to Stop Illegal Imports of Obesity Drug Ingredients
(Reuters) -The U.S. Food and Drug Administration sent an import alert on Friday to help stop illegal imports of GLP-1 drug ingredients entering the…